Enveric Biosciences Announces Patent Granted for Drug Candidate
US patent includes broad claims for treating brain neurological disorders CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of …